My line of thinking goes like this...
Any strategic partner that comes on board (which is pivotal to unlocking the value in the product) would only be willing to do so when their is a de-risking of the product. Results of successful clinical trials would illustrate a significant milestone is the aforementioned de-risking.
Therefore, where are the announcements to the market?
I feel like i'm missing a step here, does anyone else feel the same?
- Forums
- ASX - By Stock
- ALT
- Clinical Trials
Clinical Trials, page-10
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)